National Bank Of Canada Rhythm Pharmaceuticals, Inc. Transaction History

National Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$40.81 - $55.0 $2.56 Million - $3.45 Million	-62,735 Reduced 15.52%	341,507 $17.9 Million
Q2 2024 Aug 02, 2024	BUY	$35.41 - $44.37 $1.3 Million - $1.63 Million	36,725 Added 9.99%	404,242 $16.6 Million
Q1 2024 May 13, 2024	BUY	$39.12 - $52.44 $5.03 Million - $6.74 Million	128,517 Added 53.77%	367,517 $15.9 Million
Q4 2023 Feb 06, 2024	BUY	$21.39 - $49.64 $2.31 Million - $5.36 Million	108,000 Added 82.44%	239,000 $11 Million
Q3 2023 Oct 10, 2023	BUY	$15.81 - $27.8 $2.07 Million - $3.64 Million	131,000 New	131,000 $3 Million

216

64.4M

445K

26.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.79B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.